Literature DB >> 25182738

Eye movements in Alzheimer's disease.

Robert J Molitor1, Philip C Ko1, Brandon A Ally2.   

Abstract

A growing body of literature has investigated changes in eye movements as a result of Alzheimer's disease (AD). When compared to healthy, age-matched controls, patients display a number of remarkable alterations to oculomotor function and viewing behavior. In this article, we review AD-related changes to fundamental eye movements, such as saccades and smooth pursuit motion, in addition to changes to eye movement patterns during more complex tasks like visual search and scene exploration. We discuss the cognitive mechanisms that underlie these changes and consider the clinical significance of eye movement behavior, with a focus on eye movements in mild cognitive impairment. We conclude with directions for future research.

Entities:  

Keywords:  Attention; mild cognitive impairment; saccade; smooth pursuit

Mesh:

Year:  2015        PMID: 25182738      PMCID: PMC5332166          DOI: 10.3233/JAD-141173

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  124 in total

1.  Model of the control of saccades by superior colliculus and cerebellum.

Authors:  C Quaia; P Lefèvre; L M Optican
Journal:  J Neurophysiol       Date:  1999-08       Impact factor: 2.714

Review 2.  Mild cognitive impairment.

Authors:  Serge Gauthier; Barry Reisberg; Michael Zaudig; Ronald C Petersen; Karen Ritchie; Karl Broich; Sylvie Belleville; Henry Brodaty; David Bennett; Howard Chertkow; Jeffrey L Cummings; Mony de Leon; Howard Feldman; Mary Ganguli; Harald Hampel; Philip Scheltens; Mary C Tierney; Peter Whitehouse; Bengt Winblad
Journal:  Lancet       Date:  2006-04-15       Impact factor: 79.321

3.  Pupillary cholinergic hypersensitivity predicts cognitive decline in community dwelling elders.

Authors:  Leonard F M Scinto
Journal:  Neurobiol Aging       Date:  2006-11-21       Impact factor: 4.673

Review 4.  Electroencephalography and event-related potentials as biomarkers of mild cognitive impairment and mild Alzheimer's disease.

Authors:  Colleen E Jackson; Peter J Snyder
Journal:  Alzheimers Dement       Date:  2007-12-21       Impact factor: 21.566

5.  Distinctive features of microsaccades in Alzheimer's disease and in mild cognitive impairment.

Authors:  Zoi Kapoula; Qing Yang; Jorge Otero-Millan; Shifu Xiao; Stephen L Macknik; Alexandre Lang; Marc Verny; Susana Martinez-Conde
Journal:  Age (Dordr)       Date:  2013-09-15

6.  Tropicamide eyedrops cannot be used for reliable diagnosis of Alzheimer's disease.

Authors:  N R Graff-Radford; S C Lin; P W Brazis; J P Bolling; T J Liesegang; J A Lucas; R J Uitti; P C O'Brien
Journal:  Mayo Clin Proc       Date:  1997-06       Impact factor: 7.616

7.  The role of visual attention in saccadic eye movements.

Authors:  J E Hoffman; B Subramaniam
Journal:  Percept Psychophys       Date:  1995-08

8.  Pupil dilation to tropicamide is not specific for Alzheimer disease.

Authors:  J H Growdon; K Graefe; M Tennis; D Hayden; D Schoenfeld; S H Wray
Journal:  Arch Neurol       Date:  1997-07

9.  Oculomotor reaction time in dementia reflects degree of cerebral dysfunction.

Authors:  F J Pirozzolo; E C Hansch
Journal:  Science       Date:  1981-10-16       Impact factor: 47.728

Review 10.  Clinical studies in Alzheimer patients with positron emission tomography.

Authors:  A Nordberg
Journal:  Behav Brain Res       Date:  1993-11-30       Impact factor: 3.332

View more
  27 in total

Review 1.  The Potential Utility of Eye Movements in the Detection and Characterization of Everyday Functional Difficulties in Mild Cognitive Impairment.

Authors:  Sarah C Seligman; Tania Giovannetti
Journal:  Neuropsychol Rev       Date:  2015-04-08       Impact factor: 7.444

2.  Digital Phenotyping in Clinical Neurology.

Authors:  Anoopum S Gupta
Journal:  Semin Neurol       Date:  2022-01-11       Impact factor: 3.212

3.  Screening Utility of the King-Devick Test in Mild Cognitive Impairment and Alzheimer Disease Dementia.

Authors:  Kristin M Galetta; Kimberly R Chapman; Maritza D Essis; Michael L Alosco; Danielle Gillard; Eric Steinberg; Diane Dixon; Brett Martin; Christine E Chaisson; Neil W Kowall; Yorghos Tripodis; Laura J Balcer; Robert A Stern
Journal:  Alzheimer Dis Assoc Disord       Date:  2017 Apr-Jun       Impact factor: 2.703

4.  Predicting eye-movement characteristics across multiple tasks from working memory and executive control.

Authors:  Steven G Luke; Emily S Darowski; Shawn D Gale
Journal:  Mem Cognit       Date:  2018-07

Review 5.  Prosaccade and Antisaccade Paradigms in Persons with Alzheimer's Disease: A Meta-Analytic Review.

Authors:  Naomi Kahana Levy; Michal Lavidor; Eli Vakil
Journal:  Neuropsychol Rev       Date:  2017-10-27       Impact factor: 7.444

6.  Eye Tracking Analysis of Visual Cues during Wayfinding in Early Stage Alzheimer's Disease.

Authors:  Rebecca Davis; Alla Sikorskii
Journal:  Dement Geriatr Cogn Disord       Date:  2020-06-09       Impact factor: 2.959

7.  To Explore the Predictive Power of Visuomotor Network Dysfunctions in Mild Cognitive Impairment and Alzheimer's Disease.

Authors:  Justine Staal; Francesco Mattace-Raso; Hennie A M Daniels; Johannes van der Steen; Johan J M Pel
Journal:  Front Neurosci       Date:  2021-06-28       Impact factor: 4.677

Review 8.  Saccadic Eye Movement in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis.

Authors:  Julius Opwonya; Dieu Ni Thi Doan; Seul Gee Kim; Joong Il Kim; Boncho Ku; Soochan Kim; Sunju Park; Jaeuk U Kim
Journal:  Neuropsychol Rev       Date:  2021-05-06       Impact factor: 6.940

9.  Cognitive load influences oculomotor behavior in natural scenes.

Authors:  Kerri Walter; Peter Bex
Journal:  Sci Rep       Date:  2021-06-11       Impact factor: 4.379

10.  A cross-sectional study in healthy elderly subjects aimed at development of an algorithm to increase identification of Alzheimer pathology for the purpose of clinical trial participation.

Authors:  Samantha Prins; Ahnjili Zhuparris; Ellen P Hart; Robert-Jan Doll; Geert Jan Groeneveld
Journal:  Alzheimers Res Ther       Date:  2021-07-17       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.